Jane E. Rady

SightLife, Inc. is a non-profit organization which provides eye care services. It focuses on the elimination of corneal blindness. The organization was founded by Jack Smalley in 1969 and is headquartered in Seattle, WA.

Lions Eye Institute For Transplant & Research distributes eye tissue for transplantation. The firm provides blind or visually impaired through innovative ocular endeavors. It works to educate and inspire communities about ocular research as well as host and fund special events to help people understand that blindness is something everyone faces. The company is headquartered in Tampa, FL.

Abbott Medical Optics, Inc. develops and manufactures medical devices and supplies for eye care. Its products include star s4 IR excimer laser, wavescan wavefront system, intralase FS laser, catalys precision laser system, tecnis iTec preloaded delivery system, compact intuitiv system and ultrazyme enzymatic cleaner. The firm also offers customer and technical support, service agreement, practice development and intralase electronic procedure services. The company was founded in 1976 and is headquartered in Santa Ana, CA.

Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA.

Part of Sanofi, Lorex Pharmaceuticals is an American company that manufactures pharmaceutical products. The private company is located in the US. The company was founded in 1990. Lorex Pharmaceuticals was acquired by Sanofi from Monsanto Co. on May 01, 1998.

Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service.